| Drug Name |
Isoniazid |
| Drug ID |
BADD_D01204 |
| Description |
Antibacterial agent used primarily as a tuberculostatic. It remains the treatment of choice for tuberculosis. |
| Indications and Usage |
For the treatment of all forms of tuberculosis in which organisms are susceptible. |
| Marketing Status |
approved; investigational |
| ATC Code |
J04AC01 |
| DrugBank ID |
DB00951
|
| KEGG ID |
D00346
|
| MeSH ID |
D007538
|
| PubChem ID |
3767
|
| TTD Drug ID |
D09XQF
|
| NDC Product Code |
60687-553; 0555-0071; 71610-395; 83112-071; 50090-0410; 63187-978; 0555-0066; 68788-9405; 71610-108; 12785-0003; 50090-0370; 70518-0096; 70518-2576; 43063-463; 62135-550; 0781-3056; 12785-0002; 66639-914; 51079-083; 43367-0100; 71052-611; 46287-009; 71335-0275; 53002-2920 |
| UNII |
V83O1VOZ8L
|
| Synonyms |
Isoniazid | Isonicotinic Acid Hydrazide | Hydrazide, Isonicotinic Acid | Phthivazide | Phthivazid | Isonicotinic Acid Vanillylidenehydrazide | Acid Vanillylidenehydrazide, Isonicotinic | Vanillylidenehydrazide, Isonicotinic Acid | Ftivazide | Tubazide | Isonex |
